Literature DB >> 29607298

Timing of the Treatment of Portal Vein Thrombosis in Patients with Cirrhosis: A German Hepatologist's Perspective.

Martin Rössle1, Michael Schultheiss1.   

Abstract

Entities:  

Year:  2018        PMID： 29607298      PMCID： PMC5874481          DOI： 10.2478/jtim-2018-0003

Source DB:  PubMed          Journal:  J Transl Int Med        ISSN： 2224-4018


× No keyword cloud information.
  31 in total

1.  Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis.

Authors:  Lucio Amitrano; Maria Anna Guardascione; Antonella Menchise; Rossana Martino; Mariano Scaglione; Sabrina Giovine; Luigia Romano; Antonio Balzano
Journal:  J Clin Gastroenterol       Date:  2010-07       Impact factor: 3.062

2.  Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study.

Authors:  Filipe Nery; Sylvie Chevret; Bertrand Condat; Emmanuelle de Raucourt; Larbi Boudaoud; Pierre-Emmanuel Rautou; Aurelie Plessier; Dominique Roulot; Cendrine Chaffaut; Valerie Bourcier; Jean-Claude Trinchet; Dominique-Charles Valla
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

3.  Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.

Authors:  Marco Senzolo; Teresa M Sartori; Valeria Rossetto; Patrizia Burra; Umberto Cillo; Patrizia Boccagni; Daniele Gasparini; Diego Miotto; Paolo Simioni; Emmanuel Tsochatzis; Kenneth A Burroughs
Journal:  Liver Int       Date:  2012-03-21       Impact factor: 5.828

4.  Efficacy of transjugular intrahepatic portosystemic shunt to prevent total portal vein thrombosis in cirrhotic patients awaiting for liver transplantation.

Authors:  D D'Avola; J I Bilbao; G Zozaya; F Pardo; F Rotellar; M Iñarrairaegui; J Quiroga; B Sangro; J I Herrero
Journal:  Transplant Proc       Date:  2012-11       Impact factor: 1.066

5.  Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis.

Authors:  Yong Lv; Chuangye He; Zhengyu Wang; Wengang Guo; Jianhong Wang; Wei Bai; Lei Zhang; Qiuhe Wang; Haibo Liu; Bohan Luo; Jing Niu; Kai Li; Jun Tie; Zhanxin Yin; Daiming Fan; Guohong Han
Journal:  Radiology       Date:  2017-07-05       Impact factor: 11.105

6.  The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis.

Authors:  Jason Bauer; Stephen Johnson; Janette Durham; Michael Ludkowski; James Trotter; Thomas Bak; Michael Wachs
Journal:  Liver Transpl       Date:  2006-10       Impact factor: 5.799

7.  Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis.

Authors:  Jean-Marc Perarnau; Alice Baju; Louis D'alteroche; Jérôme Viguier; Jean Ayoub
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-09       Impact factor: 2.566

8.  Pretransplantation Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Final Analysis of a 61-Patient Cohort.

Authors:  Bartley Thornburg; Kush Desai; Ryan Hickey; Elias Hohlastos; Laura Kulik; Daniel Ganger; Talia Baker; Michael Abecassis; Juan C Caicedo; Daniela Ladner; Jonathan Fryer; Ahsun Riaz; Robert J Lewandowski; Riad Salem
Journal:  J Vasc Interv Radiol       Date:  2017-10-17       Impact factor: 3.464

9.  Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.

Authors:  Yong Lv; Xingshun Qi; Chuangye He; Zhengyu Wang; Zhanxin Yin; Jing Niu; Wengang Guo; Wei Bai; Hongbo Zhang; Huahong Xie; Liping Yao; Jianhong Wang; Tao Li; Qiuhe Wang; Hui Chen; Haibo Liu; Enxing Wang; Dongdong Xia; Bohan Luo; Xiaomei Li; Jie Yuan; Na Han; Ying Zhu; Jielai Xia; Hongwei Cai; Zhiping Yang; Kaichun Wu; Daiming Fan; Guohong Han
Journal:  Gut       Date:  2017-09-28       Impact factor: 23.059

10.  Techniques of TIPS in the treatment of liver cirrhosis combined with incompletely occlusive main portal vein thrombosis.

Authors:  Mengfei Zhao; Zhendong Yue; Hongwei Zhao; Lei Wang; Zhenhua Fan; Fuliang He; Jiannan Yao; Xiaoqun Dong; Fuquan Liu
Journal:  Sci Rep       Date:  2016-09-13       Impact factor: 4.379
View more
  2 in total

1.  Cytokines predict virological response in chronic hepatitis B patients receiving peginterferon alfa-2a therapy.

Authors:  Wen-Kang Fu; Jie Cao; Ning-Ning Mi; Chong-Fei Huang; Long Gao; Jin-Duo Zhang; Ping Yue; Bing Bai; Yan-Yan Lin; Wen-Bo Meng
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

2.  Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus.

Authors:  Ellen G Driever; Fien A von Meijenfeldt; Jelle Adelmeijer; Robbert J de Haas; Marius C van den Heuvel; Chandrasekaran Nagasami; John W Weisel; Constantino Fondevila; Robert J Porte; Anabel Blasi; Nigel Heaton; Stephen Gregory; Pauline Kane; William Bernal; Yoh Zen; Ton Lisman
Journal:  Hepatology       Date:  2021-12-05       Impact factor: 17.298
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.